Trial
NCT06013371
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Pfizer
Condition
Seborrheic Dermatitis
Intervention
PF-07038124
Why stopped
The study ended early because interim analysis showed no significant difference between the active and placebo arms.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-24